Inventor · disambiguated record
Robert Kreitman
Also filed as: KREITMAN ROBERT · KREITMAN ROBERT J
10 granted patents·3 pending applications·511 citations·filing 1994–2012
92Inventor score
Files withUS HEALTH7FITZGERALD DAVID J1GOVERNMENT OF U S A AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES1KREITMAN ROBERT J1PASTAN IRA1
Top patents by PatentIndex Score
13 records- 0196US7355012B2Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cellsUS HEALTH·Filed 2002·Granted Apr 8, 2008·99 cites·28 claims
- 0294US7521054B2Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric pointUS HEALTH·Filed 2001·Granted Apr 21, 2009·72 cites·8 claims
- 0393US7777019B2Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cellsUS HEALTH·Filed 2008·Granted Aug 17, 2010·16 cites·24 claims
- 0493US6011002ACircularly permuted ligands and circularly permuted chimeric moleculesUS HEALTH·Filed 1995·Granted Jan 4, 2000·116 cites·50 claims
- 0590US8809502B2Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cellsPASTAN IRA·Filed 2012·Granted Aug 19, 2014·12 cites·18 claims
- 0690US7541034B1Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumorsUS HEALTH·Filed 1998·Granted Jun 2, 2009·93 cites·1 claims
- 0788US5635599AFusion proteins comprising circularly permuted ligandsUS HEALTH·Filed 1994·Granted Jun 3, 1997·72 cites·17 claims
- 0886US9592304B2Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumorsFITZGERALD DAVID J·Filed 2009·Granted Mar 14, 2017·7 cites·1 claims
- 0983US7470775B2Anti-CD30 stalk and anti-CD30 antibodies suitable for use in immunotoxinsUS HEALTH·Filed 2003·Granted Dec 30, 2008·18 cites·37 claims
- 1082US8907060B2Mutated Pseudomonas exotoxins with reduced antigenicityPASTAN IRA H·Filed 2006·Granted Dec 9, 2014·6 cites·105 claims
- 1158US2011065185A1Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cellsGOVERNMENT OF U S A AS REPRESENTED BY THE SECRETARY OF THE DEPT OF HEALTH AND HUMAN SERVICES·Filed 2010·Application pending·0 cites
- 1246US2004018203A1Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugatesFiled 2001·Application pending·0 cites
- 1344US2005244828A1Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphomaKREITMAN ROBERT J·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →